SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsArchive2026-11-12

Thu, Nov 12, 2026 - Page 72

13819 indexed SquawkNews stories from this UTC day. Showing 8521-8640.

EQUITY 5982EARNINGS 4842FX 653NEWS 460CENTRAL_BANK 417MACRO 293GEOPOLITICS 273REGULATION 219MNA 175RATES 149ENERGY 148COMMODITIES 145
L AUXLY CANNABIS Q3 REVENUE CAD 49.5 MILLION AUXLY CANNABIS Q3 REVENUE CAD 49.5 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L Aya Gold & Silver Reports Strong Q3-2026 Results on Record Production and Lower Cash Costs MONTREAL, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. COMMODITIES | Nov 12, 2026, 12:01 PM UTC L AUXLY REPORTS THIRD QUARTER 2026 RESULTS AUXLY REPORTS THIRD QUARTER 2026 RESULTS EQUITY | Nov 12, 2026, 12:01 PM UTC L Deep Isolation Nuclear, Inc. Reports Operational and Financial Results for the Third Quarter of 2026 Operational Highlights for the Third Quarter of 2026 Common stock approved for quotation and began t EQUITY | Nov 12, 2026, 12:01 PM UTC L Acurx Pharmaceuticals, Inc. Reports Third Quarter 2026 results and provides business update STATEN ISLAND, N.Y., Nov. 12, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. EQUITY | Nov 12, 2026, 12:01 PM UTC L Legence Reports Third Quarter 2026 Financial Results Record Quarterly Revenues of $1.31 Billion, an 85% Increase from a Year Ago Excluding Bowers Acquisi EQUITY | Nov 12, 2026, 12:01 PM UTC L CELLEBRITE REPORTS THIRD-QUARTER 2026 RESULTS CELLEBRITE REPORTS THIRD-QUARTER 2026 RESULTS EQUITY | Nov 12, 2026, 12:01 PM UTC L AUXLY CANNABIS Q3 ADJUSTED EBITDA CAD 15.8 MILLION AUXLY CANNABIS Q3 ADJUSTED EBITDA CAD 15.8 MILLION FX | Nov 12, 2026, 12:01 PM UTC L AUXLY REPORTS THIRD QUARTER 2026 RESULTS AUXLY REPORTS THIRD QUARTER 2026 RESULTS EQUITY | Nov 12, 2026, 12:01 PM UTC L AUXLY CANNABIS Q3 NET INCOME CAD 13.6 MILLION AUXLY CANNABIS Q3 NET INCOME CAD 13.6 MILLION FX | Nov 12, 2026, 12:01 PM UTC L HYPERION DEFI Q3 ADJUSTED GROSS PROFIT USD 2.795 MILLION HYPERION DEFI Q3 ADJUSTED GROSS PROFIT USD 2.795 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L CELLEBRITE OUTLOOK FY ADJUSTED EBITDA USD 163-166 MILLION VS. IBES ESTIMATE USD 155.3 MILLION CELLEBRITE OUTLOOK FY ADJUSTED EBITDA USD 163-166 MILLION VS. IBES ESTIMATE USD 155.3 MILLION FX | Nov 12, 2026, 12:01 PM UTC L Cascade Copper Confirms High-Grade Intercepts in Historic Drill Core Resampling of historic Copper Plateau drill core returned 1.713% CuEq over 19.86m and 3.211% CuEq over 10.13m. EQUITY | Nov 12, 2026, 12:01 PM UTC L Data I/O Reports Third Quarter 2026 Results REDMOND, Wash., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Data I/O Corporation (NASDAQ: DAIO), the leading g EQUITY | Nov 12, 2026, 12:01 PM UTC L DEEP ISOLATION NUCLEAR, INC. REPORTS OPERATIONAL AND FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2026 DEEP ISOLATION NUCLEAR, INC. REPORTS OPERATIONAL AND FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2026 EQUITY | Nov 12, 2026, 12:01 PM UTC L CARDIFF ONCOLOGY REPORTS THIRD QUARTER 2026 RESULTS AND PROVIDES BUSINESS UPDATE CARDIFF ONCOLOGY REPORTS THIRD QUARTER 2026 RESULTS AND PROVIDES BUSINESS UPDATE EQUITY | Nov 12, 2026, 12:01 PM UTC M Dilip Buildcon Profit Falls 52.8% as Quarterly Revenue Rises 16.8% Dilip Buildcon reported consolidated net profit of ₹101 crore for the September quarter, down 52.8% year on year from ₹214 crore. Revenue from operations increased 16.8% to ₹2,250.4 crore from ₹1,926 crore. EQUITY | Nov 12, 2026, 12:01 PM UTC L NETSOL TECHNOLOGIES INC. Q1 ADJUSTED EBITDA USD 480 THOUSAND NETSOL TECHNOLOGIES INC. Q1 ADJUSTED EBITDA USD 480 THOUSAND FX | Nov 12, 2026, 12:01 PM UTC L DATA I/O REPORTS THIRD QUARTER 2026 RESULTS DATA I/O REPORTS THIRD QUARTER 2026 RESULTS EQUITY | Nov 12, 2026, 12:01 PM UTC H Hyperion DeFi Reports Q3 2026 Financial Results with Third Consecutive Quarterly Record Net Income, Achieving Breakeven Guidance on Core Ope Hyperion DeFi Reports Q3 2026 Financial Results with Third Consecutive Quarterly Record Net Income, EARNINGS | Nov 12, 2026, 12:01 PM UTC L CELLEBRITE Q3 NET INCOME USD 26.656 MILLION VS. IBES ESTIMATE USD 39.7 MILLION CELLEBRITE Q3 NET INCOME USD 26.656 MILLION VS. IBES ESTIMATE USD 39.7 MILLION FX | Nov 12, 2026, 12:01 PM UTC L HLS THERAPEUTICS Q3 PRETAX PROFIT USD -2.235 MILLION HLS THERAPEUTICS Q3 PRETAX PROFIT USD -2.235 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L HLS THERAPEUTICS Q3 NET INCOME USD -2.226 MILLION HLS THERAPEUTICS Q3 NET INCOME USD -2.226 MILLION FX | Nov 12, 2026, 12:01 PM UTC L Octave Announces Third Quarter 2026 Financial Results Octave Announces Third Quarter 2026 Financial Results Total revenue of $415 million, an increase of EARNINGS | Nov 12, 2026, 12:01 PM UTC M Tidewater Renewables Raises 2026 Adjusted EBITDA Guidance to $165M–$175M The company lifted its 2026 Adjusted EBITDA guidance from $130M–$140M. Q3 Adjusted EBITDA was $54.6M, versus $16.4M a year earlier; net loss was $15.6M, versus $1.0M. EARNINGS | Nov 12, 2026, 12:01 PM UTC L AVEANNA HEALTHCARE Q3 ADJUSTED EBITDA USD 100.1 MILLION AVEANNA HEALTHCARE Q3 ADJUSTED EBITDA USD 100.1 MILLION FX | Nov 12, 2026, 12:01 PM UTC L Cardiff Oncology Reports Third Quarter 2026 Results and Provides Business Update Cardiff Oncology Reports Third Quarter 2026 Results and Provides Business Update Phase 2 trial remai EQUITY | Nov 12, 2026, 12:01 PM UTC H Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 Guidance Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 Guidance Thir EARNINGS | Nov 12, 2026, 12:01 PM UTC L NETSOL Technologies reports fiscal first quarter 2027 revenue growth of 9.3% and gross margin expansion to 50.5% ENCINO, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. EARNINGS | Nov 12, 2026, 12:01 PM UTC L NETSOL TECHNOLOGIES INC. Q1 GROSS PROFIT USD 8.3 MILLION NETSOL TECHNOLOGIES INC. Q1 GROSS PROFIT USD 8.3 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L Xanadu Q3 net loss widens 59% to USD 32.2 million Xanadu Q3 net loss widens 59% to USD 32.2 million Xanadu's third-quarter 2026 net loss widened 5 FX | Nov 12, 2026, 12:01 PM UTC L CELLEBRITE Q3 ADJUSTED EBITDA USD 53.625 MILLION VS. IBES ESTIMATE USD 43.3 MILLION CELLEBRITE Q3 ADJUSTED EBITDA USD 53.625 MILLION VS. IBES ESTIMATE USD 43.3 MILLION FX | Nov 12, 2026, 12:01 PM UTC L AVEANNA HEALTHCARE Q3 REVENUE USD 695.5 MILLION VS. IBES ESTIMATE USD 679.5 MILLION AVEANNA HEALTHCARE Q3 REVENUE USD 695.5 MILLION VS. IBES ESTIMATE USD 679.5 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L SOLV ENERGY Q3 NET INCOME USD 123 MILLION SOLV ENERGY Q3 NET INCOME USD 123 MILLION FX | Nov 12, 2026, 12:01 PM UTC L TIDEWATER RENEWABLES Q3 REVENUE CAD 239.9 MILLION TIDEWATER RENEWABLES Q3 REVENUE CAD 239.9 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L CELLEBRITE Q3 OPERATING INCOME USD 26.875 MILLION CELLEBRITE Q3 OPERATING INCOME USD 26.875 MILLION FX | Nov 12, 2026, 12:01 PM UTC L ProQR Therapeutics 3Q Loss/Shr EUR0.09 >PRQR ProQR Therapeutics 3Q Loss/Shr EUR0.09 >PRQR EQUITY | Nov 12, 2026, 12:01 PM UTC M AYA GOLD & SILVER INC Q3 REVENUE USD 103 MILLION AYA GOLD & SILVER INC Q3 REVENUE USD 103 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L SATELLOS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS COMPANY PROGRESS SATELLOS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS COMPANY PROGRESS EQUITY | Nov 12, 2026, 12:01 PM UTC L PELTHOS THERAPEUTICS Q3 ADJUSTED EBITDA USD -5.6 MILLION PELTHOS THERAPEUTICS Q3 ADJUSTED EBITDA USD -5.6 MILLION FX | Nov 12, 2026, 12:01 PM UTC M AYA GOLD & SILVER INC Q3 NET INCOME USD 35 MILLION AYA GOLD & SILVER INC Q3 NET INCOME USD 35 MILLION COMMODITIES | Nov 12, 2026, 12:01 PM UTC L BROADWIND Q3 REVENUE USD 22.3 MILLION BROADWIND Q3 REVENUE USD 22.3 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L Table: GeoVision Inc 3Q Net Profit NT$132.1M Vs NT$260.8M GeoVision Inc. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$318,231,000 NT$236,440,000 Pretax Profit NT$140,447,000 NT$261,501,000 Net Profit NT$132,1… EARNINGS | Nov 12, 2026, 12:01 PM UTC L MEDIWOUND REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE MEDIWOUND REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE EQUITY | Nov 12, 2026, 12:01 PM UTC L MEDIWOUND Q3 EPS USD -0.46 MEDIWOUND Q3 EPS USD -0.46 EARNINGS | Nov 12, 2026, 12:01 PM UTC L BROADWIND Q3 ADJUSTED EBITDA USD 500 THOUSAND BROADWIND Q3 ADJUSTED EBITDA USD 500 THOUSAND FX | Nov 12, 2026, 12:01 PM UTC L OCTAVE ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS OCTAVE ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS EQUITY | Nov 12, 2026, 12:01 PM UTC L SYSTEX Corp 3Q Net Profit NT$373.8M Vs NT$605.4M SYSTEX Corp 3Q Net Profit NT$373.8M Vs NT$605.4M EARNINGS | Nov 12, 2026, 12:01 PM UTC M AYA GOLD & SILVER INC Q3 OPERATING CASH FLOW USD 48 MILLION AYA GOLD & SILVER INC Q3 OPERATING CASH FLOW USD 48 MILLION COMMODITIES | Nov 12, 2026, 12:01 PM UTC L Cascade Copper Reports High-Grade Drill Intercepts at BC Project The company reported resampling results from its Copper Plateau Porphyry Project, including 1.713% CuEq over 19.86m and 3.211% CuEq over 10.13m. EQUITY | Nov 12, 2026, 12:01 PM UTC H HYPERION DEFI REPORTS Q3 2026 FINANCIAL RESULTS WITH THIRD CONSECUTIVE QUARTERLY RECORD NET INCOME, ACHIEVING BREAKEVEN GUIDANCE ON CORE OPE HYPERION DEFI REPORTS Q3 2026 FINANCIAL RESULTS WITH THIRD CONSECUTIVE QUARTERLY RECORD NET INCOME, EARNINGS | Nov 12, 2026, 12:01 PM UTC L MEDIWOUND Q3 NET INCOME USD -6 MILLION MEDIWOUND Q3 NET INCOME USD -6 MILLION FX | Nov 12, 2026, 12:01 PM UTC L PELTHOS THERAPEUTICS Q3 NET INCOME USD -7.895 MILLION PELTHOS THERAPEUTICS Q3 NET INCOME USD -7.895 MILLION FX | Nov 12, 2026, 12:01 PM UTC L LEGENCE CORP Q3 EPS USD 1.15 LEGENCE CORP Q3 EPS USD 1.15 EARNINGS | Nov 12, 2026, 12:01 PM UTC M AYA GOLD & SILVER REPORTS STRONG Q3-2026 RESULTS ON RECORD PRODUCTION AND LOWER CASH COSTS AYA GOLD & SILVER REPORTS STRONG Q3-2026 RESULTS ON RECORD PRODUCTION AND LOWER CASH COSTS COMMODITIES | Nov 12, 2026, 12:01 PM UTC L HLS THERAPEUTICS Q3 REVENUE USD 14.155 MILLION HLS THERAPEUTICS Q3 REVENUE USD 14.155 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L PELTHOS THERAPEUTICS Q3 OPERATING INCOME USD -9.693 MILLION PELTHOS THERAPEUTICS Q3 OPERATING INCOME USD -9.693 MILLION FX | Nov 12, 2026, 12:01 PM UTC L LEGENCE CORP Q3 GROSS PROFIT USD 275.5 MILLION LEGENCE CORP Q3 GROSS PROFIT USD 275.5 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L Solv Energy Reports Third Quarter 2026 Financial Results Solv Energy Reports Third Quarter 2026 Financial Results SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) EQUITY | Nov 12, 2026, 12:01 PM UTC L PELTHOS THERAPEUTICS ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE PELTHOS THERAPEUTICS ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE EQUITY | Nov 12, 2026, 12:01 PM UTC L DATA I/O CORPORATION Q3 EPS USD -0.27 DATA I/O CORPORATION Q3 EPS USD -0.27 EARNINGS | Nov 12, 2026, 12:01 PM UTC H AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER FINANCIAL RESULTS AND REVISED 2026 GUIDANCE AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER FINANCIAL RESULTS AND REVISED 2026 GUIDANCE EARNINGS | Nov 12, 2026, 12:01 PM UTC L Data I/O Reports Third Quarter 2026 Results Data I/O Reports Third Quarter 2026 Results REDMOND, Wash., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Data I EQUITY | Nov 12, 2026, 12:01 PM UTC L Deep Isolation Nuclear, Inc. Reports Operational and Financial Results for the Third Quarter of 2026 Deep Isolation Nuclear, Inc. Reports Operational and Financial Results for the Third Quarter of 2026 EQUITY | Nov 12, 2026, 12:01 PM UTC L HLS THERAPEUTICS ANNOUNCES Q3 2026 FINANCIAL RESULTS HLS THERAPEUTICS ANNOUNCES Q3 2026 FINANCIAL RESULTS EQUITY | Nov 12, 2026, 12:01 PM UTC H TIDEWATER MIDSTREAM AND INFRASTRUCTURE LTD. ANNOUNCES THIRD QUARTER 2026 RESULTS, OPERATIONAL UPDATE, AND FURTHER INCREASE TO 2026 FINANCIAL TIDEWATER MIDSTREAM AND INFRASTRUCTURE LTD. ANNOUNCES THIRD QUARTER 2026 RESULTS, OPERATIONAL UPDATE EARNINGS | Nov 12, 2026, 12:01 PM UTC L Broadwind Announces Third Quarter 2026 Results CICERO, Ill., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a divers EQUITY | Nov 12, 2026, 12:01 PM UTC L GXO and Apptronik Expand Partnership on Humanoid Robots GXO and Apptronik signed a letter of intent to expand operational trials of Apollo humanoid robots and develop fram EQUITY | Nov 12, 2026, 12:01 PM UTC M Tidewater Renewables Reports Q3 Results, Raises 2026 Guidance Tidewater Renewables announced third-quarter 2026 results and increased 2026 guidance. It also provided an update on a proposed transaction with Tidewater Midstream and operations. EQUITY | Nov 12, 2026, 12:01 PM UTC L SOLV ENERGY REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS SOLV ENERGY REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS EQUITY | Nov 12, 2026, 12:01 PM UTC L TIDEWATER RENEWABLES Q3 ADJUSTED EBITDA CAD 54.6 MILLION TIDEWATER RENEWABLES Q3 ADJUSTED EBITDA CAD 54.6 MILLION FX | Nov 12, 2026, 12:01 PM UTC L MEDIWOUND Q3 REVENUE USD 3.6 MILLION VS. IBES ESTIMATE USD 6.73 MILLION MEDIWOUND Q3 REVENUE USD 3.6 MILLION VS. IBES ESTIMATE USD 6.73 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L Acurx Pharmaceuticals, Inc. Reports Third Quarter 2026 results and provides business update STATEN ISLAND, N.Y., Nov. 12, 2026 // -- Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for serious or life-threatening EQUITY | Nov 12, 2026, 12:01 PM UTC M Cellebrite Raises 2026 Adjusted EBITDA Outlook to $163M–$166M Cellebrite reported Q3 net income of $26.7 million and adjusted EBITDA of $53.6 million, with ARR growth of 20%. It reaffirmed its full-year ARR outlook. EARNINGS | Nov 12, 2026, 12:01 PM UTC L HLS Therapeutics Inc. (HLS) Q3 Revenue Rose 5%; Net Loss Narrowed to $2.2M Q3 2026 revenue rose 5% year over year; Adjusted EBITDA was $5.0M versus $4.9M, and net loss narrowed to $2.2M from $3.9M. HLS refined 2026 targets within previously guided ranges and expects revenue and Adjusted EBITDA EARNINGS | Nov 12, 2026, 12:01 PM UTC L NETSOL TECHNOLOGIES INC. Q1 REVENUE USD 16.4 MILLION NETSOL TECHNOLOGIES INC. Q1 REVENUE USD 16.4 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L TIDEWATER RENEWABLES Q3 NET INCOME CAD -15.6 MILLION TIDEWATER RENEWABLES Q3 NET INCOME CAD -15.6 MILLION FX | Nov 12, 2026, 12:01 PM UTC L DATA I/O CORPORATION Q3 NET INCOME USD -2.702 MILLION DATA I/O CORPORATION Q3 NET INCOME USD -2.702 MILLION FX | Nov 12, 2026, 12:01 PM UTC L MEDIWOUND Q3 ADJUSTED EBITDA USD -7.4 MILLION MEDIWOUND Q3 ADJUSTED EBITDA USD -7.4 MILLION FX | Nov 12, 2026, 12:01 PM UTC L Medical Facilities Corporation (DR) Reports Q3 Results and $70.8M in Cash Medical Facilities Corporation reported Q3 and nine-month results ended September 30, 2026. Cash was $70.8M, up from $43.4M at December 31, 2025; the release cites no prior-year comparison for this cash figure.Material D EQUITY | Nov 12, 2026, 12:01 PM UTC L DATA I/O CORPORATION Q3 SALES USD 4.874 MILLION DATA I/O CORPORATION Q3 SALES USD 4.874 MILLION FX | Nov 12, 2026, 12:01 PM UTC L NETSOL Technologies reports fiscal first quarter 2027 revenue growth of 9.3% and gross margin expansion to 50.5% NETSOL Technologies reports fiscal first quarter 2027 revenue growth of 9.3% and gross margin expans EARNINGS | Nov 12, 2026, 12:01 PM UTC L SOLV ENERGY Q3 REVENUE USD 1,242 MILLION SOLV ENERGY Q3 REVENUE USD 1,242 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L SOLV ENERGY Q3 PRETAX PROFIT USD 143.766 MILLION SOLV ENERGY Q3 PRETAX PROFIT USD 143.766 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC M Aya Gold & Silver Reports Strong Q3-2026 Results on Record Production and Lower Cash Costs Aya Gold & Silver Reports Strong Q3-2026 Results on Record Production and Lower Cash Costs MONTREAL, COMMODITIES | Nov 12, 2026, 12:01 PM UTC L Table: SeSoda Corp 3Q Net Profit NT$398.1M Vs NT$265.6M SeSoda Corp. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$1,966,454,000 NT$1,557,412,000 Pretax Profit NT$492,192,000 NT$333,138,000 Net Profit… EARNINGS | Nov 12, 2026, 12:01 PM UTC L Table: TXC Corp 3Q Net Profit NT$707.0M Vs NT$511.9M TXC Corp. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$4,195,503,000 NT$3,491,645,000 Pretax Profit NT$852,122,000 NT$628,608,000 Net Profit… EARNINGS | Nov 12, 2026, 12:01 PM UTC L Baker Hughes and TPAO to Explore Geothermal Opportunities in Turkey Baker Hughes and TPAO will explore opportunities for enhanced geothermal systems in Turkey. ENERGY | Nov 12, 2026, 12:01 PM UTC L Nvidia Investors Question Company’s Prospects if Huang Leaves AJ Bell’s Russ Mould writes that investors may question whether Nvidia can remain as successful if CEO Jensen Huang leaves. The Wall Street Journal reported the board was planning to discuss Huang’s future. EQUITY | Nov 12, 2026, 12:01 PM UTC L Auxly Reports Third Quarter 2026 Results TORONTO, Nov. 12, 2026 /PRNewswire/ -- Auxly Cannabis Group Inc. EQUITY | Nov 12, 2026, 12:01 PM UTC L NG ENERGY ANNOUNCES FILING OF RECORD Q3 2026 FINANCIAL RESULTS Record natural gas volumes and realized price; Operating Netback positive as unit costs fall; Arucha ENERGY | Nov 12, 2026, 12:01 PM UTC L Moderna Expects 2026 Rev. Growth Of 15% To 25% Moderna Expects 2026 Rev. Growth Of 15% To 25% NEWS | Nov 12, 2026, 12:01 PM UTC L Table: SYSTEX Corp 3Q Net Profit NT$373.8M Vs NT$605.4M SYSTEX Corp. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$19,016,764,000 NT$12,620,805,000 Pretax Profit NT$513,357,000 NT$722,227,000 Net Profit… EARNINGS | Nov 12, 2026, 12:01 PM UTC L LEGENCE CORP Q3 ADJUSTED EBITDA USD 177 MILLION LEGENCE CORP Q3 ADJUSTED EBITDA USD 177 MILLION FX | Nov 12, 2026, 12:01 PM UTC L NETSOL TECHNOLOGIES REPORTS FISCAL FIRST QUARTER 2027 REVENUE GROWTH OF 9.3% AND GROSS MARGIN EXPANSION TO 50.5% NETSOL TECHNOLOGIES REPORTS FISCAL FIRST QUARTER 2027 REVENUE GROWTH OF 9.3% AND GROSS MARGIN EXPANS EARNINGS | Nov 12, 2026, 12:01 PM UTC L LEGENCE CORP Q3 REVENUE USD 1,310 MILLION LEGENCE CORP Q3 REVENUE USD 1,310 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L TIDEWATER RENEWABLES Q3 BASIC EPS CAD -0.43 TIDEWATER RENEWABLES Q3 BASIC EPS CAD -0.43 EARNINGS | Nov 12, 2026, 12:01 PM UTC L Table: Jinli Group Holdings 3Q Net Profit NT$3.68M Vs NT$3.28M Jinli Group Holdings Ltd. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$38,017,000 NT$32,211,000 Pretax Profit NT$4,097,000 NT$3,451,000 Net Profit NT… EARNINGS | Nov 12, 2026, 12:01 PM UTC L TSCAN THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE TSCAN THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE EQUITY | Nov 12, 2026, 12:01 PM UTC L Cellebrite Reports Third-Quarter 2026 Results Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; No EQUITY | Nov 12, 2026, 12:01 PM UTC L Sri Lankan Shares Close Higher as Communications Stocks Rise Sri Lankan shares closed higher, lifted by communications stocks. EQUITY | Nov 12, 2026, 12:01 PM UTC L Astrosalva Therapeutics Adds Michael MacLean to Strategic Advisory Board The company named the former Akcea and Avidity finance chief to its advisory board. EQUITY | Nov 12, 2026, 12:01 PM UTC L MediWound Reports Third Quarter 2026 Financial Results and Provides Corporate Update EscharEx® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by EQUITY | Nov 12, 2026, 12:01 PM UTC L NIQ GLOBAL INTELLIGENCE PLC Q3 OPERATING INCOME USD 106.4 MILLION NIQ GLOBAL INTELLIGENCE PLC Q3 OPERATING INCOME USD 106.4 MILLION FX | Nov 12, 2026, 12:01 PM UTC L TScan Therapeutics 3Q Rev $600,000 >TCRX TScan Therapeutics 3Q Rev $600,000 >TCRX EQUITY | Nov 12, 2026, 12:01 PM UTC L Broadwind Announces Third Quarter 2026 Results Broadwind Announces Third Quarter 2026 Results CICERO, Ill., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Broad EQUITY | Nov 12, 2026, 12:01 PM UTC L Chevron to Restart Iowa Biodiesel Facility Chevron will restart its Ralston biodiesel facility in Iowa. ENERGY | Nov 12, 2026, 12:01 PM UTC L MediWound 3Q Loss $16.3M >MDWD MediWound 3Q Loss $16.3M >MDWD EQUITY | Nov 12, 2026, 12:01 PM UTC L MEDICAL FACILITIES CORP Q3 INCOME FROM OPERATIONS USD 11.985 MILLION MEDICAL FACILITIES CORP Q3 INCOME FROM OPERATIONS USD 11.985 MILLION FX | Nov 12, 2026, 12:01 PM UTC L Table: Realtek Semiconductor 3Q Net Profit NT$4.13B Vs NT$3.43B Realtek Semiconductor Corp. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$37,731,811,000 NT$29,491,139,000 Pretax Profit NT$4,750,245,000 NT$4,045,029,000 Ne… EARNINGS | Nov 12, 2026, 12:01 PM UTC L ENCORE ENERGY REPORTS THIRD QUARTER 2026 FINANCIAL AND OPERATING RESULTS ENCORE ENERGY REPORTS THIRD QUARTER 2026 FINANCIAL AND OPERATING RESULTS EQUITY | Nov 12, 2026, 12:01 PM UTC L Pelthos Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update Pelthos Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update Zel EQUITY | Nov 12, 2026, 12:01 PM UTC L AMERICAN SHARED HOSPITAL SERVICES REPORTS THIRD QUARTER AND NINE-MONTH 2026 FINANCIAL RESULTS AMERICAN SHARED HOSPITAL SERVICES REPORTS THIRD QUARTER AND NINE-MONTH 2026 FINANCIAL RESULTS EQUITY | Nov 12, 2026, 12:01 PM UTC L Realtek Semiconductor 3Q Net Profit NT$4.13B Vs NT$3.43B Realtek Semiconductor 3Q Net Profit NT$4.13B Vs NT$3.43B EARNINGS | Nov 12, 2026, 12:01 PM UTC L Auxly Reports Third Quarter 2026 Results TORONTO, Nov. 12, 2026 /CNW/ -- Auxly Cannabis Group Inc. EQUITY | Nov 12, 2026, 12:01 PM UTC L MediWound 3Q Rev $8.14M >MDWD MediWound 3Q Rev $8.14M >MDWD EQUITY | Nov 12, 2026, 12:01 PM UTC L MEDIWOUND Q3 GROSS PROFIT USD 1 MILLION MEDIWOUND Q3 GROSS PROFIT USD 1 MILLION EARNINGS | Nov 12, 2026, 12:01 PM UTC L METALLA REPORTS STRONG FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2026 AND ANNOUNCES INAUGURAL CASH FLOW FROM CÔTÉ AND LA PARRILLA ROYALTIES METALLA REPORTS STRONG FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2026 AND ANNOUNCES INAUGURAL CASH EQUITY | Nov 12, 2026, 12:01 PM UTC L MEDIWOUND Q3 OPERATING INCOME USD -8.5 MILLION MEDIWOUND Q3 OPERATING INCOME USD -8.5 MILLION FX | Nov 12, 2026, 12:01 PM UTC L Traws Pharma Reports Final Phase 2a Results for Ratutrelvir in COVID-infected Subjects, Showing Fewer Treatment-Related Adverse Events and N Traws Pharma Reports Final Phase 2a Results for Ratutrelvir in COVID-infected Subjects, Showing Fewe EQUITY | Nov 12, 2026, 12:01 PM UTC